Blue Rock Advisors, LLC Axonics, Inc. Transaction History
Blue Rock Advisors, LLC
- $7,000
- Q4 2023
Shares
2 transactions
Others Institutions Holding AXNX
# of Institutions
141Shares Held
28MCall Options Held
83.4KPut Options Held
65.3K-
Black Rock Inc. New York, NY4.34MShares$308 Million0.01% of portfolio
-
Westchester Capital Management, LLC Valhalla, NY1.45MShares$103 Million4.89% of portfolio
-
Mackenzie Financial Corp Toronto Ontario, A61.25MShares$88.9 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$84.1 Million0.0% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1.05MShares$74.5 Million1.56% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.49B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...